ARTELO BIOSCIENCES, INC. (ARTL)
$4.00+$0.03 (+0.76%) Latest sessionExtended Hours
Artelo Biosciences Inc is a United States-based development-stage biopharmaceutical company. It is engaged in the development of therapeutics that target lipid signaling pathways, including the endocannabinoid system, a family of receptors & neurotransmitters that form a biochemical communication network in the body. It is focused on discovering, licensing, developing, & commercializing treatments that control endocannabinoid systems. The company pursues technologies & programs that offer proprietary approaches to cannabinoid-based therapies, & those derived from the cannabis plant & synthetic cannabinoids, as well as new chemical entities & compounds. The firm's flagship program is designed to be a patent-protected cannabinoid drug combination treatment for a rare & orphan disease.
No Form 4 activity for ARTL in the last 90 days.
24 Form 4 filings on record, the earliest from Dec 23, 2024, newest first.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Gregory D. Gorgas - Officer | Other | Convertible Promissory Note | 0 | $945,000.00 | - | |
| Gregory D. Gorgas - Officer | Other | Warrant (right to buy) | 9,586 | - | - | |
| Gregory D. Gorgas - Officer | Other | Warrant (right to buy) | 17,952 | - | - | |
| Gregory D. Gorgas - Officer | Other | Convertible Promissory Note | 0 | $748,170.00 | - | |
| Connie Matsui | Other | Warrant (right to buy) | 38,346 | - | - | |
| Connie Matsui | Other | Warrant (right to buy) | 70,376 | - | - | |
| Connie Matsui | Other | Convertible Promissory Note | 0 | $2,992,761.00 | - | |
| Connie Matsui | Other | Convertible Promissory Note | 0 | $3,780,000.00 | - | |
| Tamara A. Favorito | Other | Warrant (right to buy) | 12,566 | - | - | |
| Tamara A. Favorito | Other | Convertible Promissory Note | 0 | $534,411.00 | - | |
| Tamara A. Favorito | Other | Convertible Promissory Note | 0 | $675,000.00 | - | |
| Tamara A. Favorito | Other | Warrant (right to buy) | 6,846 | - | - | |
| Gregory D. Gorgas - Officer | Grant or award | Stock Option (right to buy) | 20,393 | $0.00 | - | |
| Gregory D. Gorgas - Officer | Grant or award | Stock Option (right to buy) | 20,000 | $0.00 | - |
This is as far as the anonymous view goes. Create a free account for all 24 ARTL filings on record.
ARTELO BIOSCIENCES, INC. (ARTL) had 6 insider filings in the last 90 days, with the most recent on 2026-07-21. The full record for ARTL runs to 24 Form 4 filings, the earliest from 2024-12-23. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of ARTL were filed in the last 90 days.
No insider sales of ARTL were filed in the last 90 days.
This page tracks ARTL Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add ARTL to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
